Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACUTI: Pivmecillinam + Amoxicillin/Clavulanic Acid for Febrile UTI
NCT05224401Phase 3Recruiting
- Sponsor
- Lund University
- Start
- May 2023
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pivmecillinam, amoxicillin + clavulanate in urinary tract infection (UTI), Bacteremia, sponsored by Lund University. Started May 2023; status: recruiting.
02
Drugs
pivmecillinamamoxicillin + clavulanate
03
Conditions
urinary tract infection (UTI)Bacteremia
Beyond the preview
Go deeper on NCT05224401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05224401.